4.6 Article

Early clinical response as a predictor of efficacy in moderate to severe psoriasis patients treated with tofacitinib in a phase 2 study

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 72, Issue 5, Pages AB231

Publisher

Elsevier BV
DOI: 10.1016/j.jaad.2015.02.934

Keywords

-

Categories

Ask authors/readers for more resources

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available